Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-009805
Filing Date
2020-08-07
Accepted
2020-08-07 07:08:37
Documents
72
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q htbx-20200630x10q.htm 10-Q 1267501
2 EX-31.1 htbx-20200630ex31123900d.htm EX-31.1 15720
3 EX-31.2 htbx-20200630ex3120a149d.htm EX-31.2 15733
4 EX-32.1 htbx-20200630ex3210699c7.htm EX-32.1 7504
5 EX-32.2 htbx-20200630ex322d0f0a8.htm EX-32.2 7531
  Complete submission text file 0001558370-20-009805.txt   6206011

Data Files

Seq Description Document Type Size
6 EX-101.INS htbx-20200630.xml EX-101.INS 1319374
7 EX-101.SCH htbx-20200630.xsd EX-101.SCH 47133
8 EX-101.CAL htbx-20200630_cal.xml EX-101.CAL 75828
9 EX-101.DEF htbx-20200630_def.xml EX-101.DEF 143692
10 EX-101.LAB htbx-20200630_lab.xml EX-101.LAB 457983
11 EX-101.PRE htbx-20200630_pre.xml EX-101.PRE 357778
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35994 | Film No.: 201083703
SIC: 2834 Pharmaceutical Preparations